DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Seddon B, Strauss SJ, Whelan J. et al.
Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled
phase 3 trial.
Lancet Oncol 2017;
18: 1397-1410
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.